0001569706-18-000003.txt : 20181106 0001569706-18-000003.hdr.sgml : 20181106 20181106173319 ACCESSION NUMBER: 0001569706-18-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181026 FILED AS OF DATE: 20181106 DATE AS OF CHANGE: 20181106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Averback Paul CENTRAL INDEX KEY: 0001569706 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12033 FILM NUMBER: 181164073 MAIL ADDRESS: STREET 1: C/O NYMOX PHARMACEUTICAL CORPORATION STREET 2: 9900 CAVENDISH BLVD., SUITE 306 CITY: ST. LAURENT STATE: A8 ZIP: H4M 2V2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001018735 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 BUSINESS PHONE: 1-800-936-9669 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-10-26 0 0001018735 NYMOX PHARMACEUTICAL CORP NYMX 0001569706 Averback Paul C/O NYMOX PHARMACEUTICAL CORPORATION 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT A8 H4M 2V2 QUEBEC, CANADA 1 1 1 0 CEO Restricted Common 2018-10-26 4 S 0 100000 1.75 D 23331448 D Paul Averback 2018-11-06